Cell-Mediated Immunity Suppression and Associated Infections
All of the listed infections (herpes, cryptococcal, tuberculosis, and Pneumocystis jirovecii) result from suppression of cell-mediated immunity—the answer is E.
Understanding Cell-Mediated Immunity Defects
Cell-mediated (T-lymphocyte) immunity is the critical defense mechanism against intracellular pathogens. When this arm of immunity is compromised, patients become vulnerable to a specific and predictable group of opportunistic infections 1, 2.
High-risk populations include:
- Hodgkin and non-Hodgkin lymphoma patients
- Allogeneic hematopoietic stem cell transplant recipients
- Solid organ transplant recipients
- Patients receiving corticosteroids and immunosuppressive agents
- HIV/AIDS patients with CD4+ counts <200 cells/μL
The Specific Infections
Herpes Infections
Herpes viruses are major pathogens when cellular immunity is disrupted 2, 3. After engraftment in transplant patients, herpesviruses—particularly cytomegalovirus (CMV) and varicella-zoster virus (VZV)—become dominant pathogens 2. The reactivation of latent herpes infections has major clinical impact and represents one of the primary infection concerns in immunosuppressed patients 3. In immune-suppressed hosts, VZV lesions continue developing over 7-14 days and heal more slowly without effective antiviral therapy, potentially progressing to chronic ulcerations with persistent viral replication 1.
Cryptococcal Infections
Cryptococcal infections definitively occur in patients with cellular immune deficiency 1. These infections originate in the lungs with early hematogenous dissemination to meninges and skin or soft tissues 1. Single or multiple painless skin lesions develop in 5-10% of clinically infected patients, appearing as papules, nodules, pustules, or chronic draining necrotic ulcers 1. Notably, cutaneous lesions may precede documented cryptococcal meningitis by several weeks 1.
Tuberculosis
Tuberculosis is a classic infection associated with impaired cell-mediated immunity 4. Historically, anemia has been recognized as a risk factor for tuberculosis infections, and this relationship is mediated through impairments in both innate and adaptive immune responses 5. The suppression of cell-mediated immunity following conditions like traumatic brain injury leads to a systemic anti-inflammatory response that dampens immune regulation and increases susceptibility to infections including tuberculosis 5.
Pneumocystis jirovecii Pneumonia (PCP)
Pneumocystis jirovecii is a hallmark opportunistic infection in cell-mediated immune deficiency 6, 7. The risk of PCP relates directly to the intensity and duration of immunosuppression. Prophylaxis is indicated when patients receive prednisone equivalent of 20 mg/day for 4 weeks 6. In heavily pretreated patients with chronic lymphocytic leukemia (median 3 prior regimens), nearly 90% experienced serious infectious complications including P. jirovecii 6. PCP prophylaxis should be used when temozolomide is administered with radiation therapy and continued until recovery from lymphocytopenia 6.
Mechanistic Understanding
The underlying mechanism is straightforward: Cell-mediated immunity, mediated by CD4+ and CD8+ T cells, directly targets infected cells for elimination and suppresses pathogen replication through cytokine-mediated pathways 8. Steroids suppress cell-mediated immunity by inhibiting interleukin production crucial for T and B cell proliferation 8. When this system is compromised, the specific pathogens listed—all intracellular or requiring cellular immunity for control—can reactivate from latent states or cause progressive disease 2.
Clinical Pitfalls
Common mistake: Assuming neutropenia is the primary risk factor. Duration and severity of neutropenia are actually of lesser importance compared to sustained T-cell suppression 2, 3. The main risk factor for clinically relevant reactivation is profound disruption of cellular immune response, not simply low neutrophil counts 3.
Critical distinction: These infections differ fundamentally from those seen in neutropenic patients, where bacterial and fungal infections (Aspergillus, Candida) predominate due to impaired phagocytic function 1.